No Barriers, Wells Fargo Select 2019 Global Impact Challenge Winners

    NEXT STORY
    Spero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) Infection
    PREV STORY
    LexaGene Provides Corporate Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Myriad Genetics’ Prolaris® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated for Prostate Cancer

    author_avatar
    NASDAQ Market News

    Reata Provides Update on Bardoxolone Methyl from the American Society of Nephrology Kidney Week Meeting

    Conference call to update bardoxolone renal program today at 8:30am ET IRVING, Texas, Nov. ...

    author_avatar
    NASDAQ Market News

    aTyr Pharma Announces Leadership Transition

    – Dr. John Mendlein Transitions from CEO to Non-Executive Board Member,Dr. Sanjay Shukla Appointed President ...

    author_avatar
    NASDAQ Market News